Cargando…
Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection
Dengue is endemic throughout tropical and subtropical regions of the world. Currently, there is no clinically approved therapeutic drug available for this acute viral infection. Although the first dengue vaccine Dengvaxia has been approved for use in certain countries, it is limited to those without...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796277/ https://www.ncbi.nlm.nih.gov/pubmed/29404200 http://dx.doi.org/10.7717/peerj.3939 |
_version_ | 1783297474297856000 |
---|---|
author | Tan, Wei-Lian Lee, Yean Kee Ho, Yen Fong Yusof, Rohana Abdul Rahman, Noorsaadah Karsani, Saiful Anuar |
author_facet | Tan, Wei-Lian Lee, Yean Kee Ho, Yen Fong Yusof, Rohana Abdul Rahman, Noorsaadah Karsani, Saiful Anuar |
author_sort | Tan, Wei-Lian |
collection | PubMed |
description | Dengue is endemic throughout tropical and subtropical regions of the world. Currently, there is no clinically approved therapeutic drug available for this acute viral infection. Although the first dengue vaccine Dengvaxia has been approved for use in certain countries, it is limited to those without a previous dengue infection while the safety and efficacy of the vaccine in those elderly and younger children still need to be identified. Therefore, it is becoming increasingly important to develop therapeutics/drugs to combat dengue virus (DENV) infection. YK51 is a synthetic analogue of 4-Hydroxypandurantin A (a compound found in the crude extract of the rhizomes of Boesenbergia rotunda) that has been extensively studied by our research group. It has been shown to possess outstanding antiviral activity due to its inhibitory activity against NS2B/NS3 DENV2 protease. However, it is not known how YK51 affects the proteome of DENV infected cells. Therefore, we performed a comparative proteomics analysis to identify changes in protein expression in DENV infected HepG2 cells treated with YK51. Classical two-dimensional gel electrophoresis followed by protein identification using tandem mass spectrometry was employed in this study. Thirty proteins were found to be down-regulated with YK51 treatment. In silico analysis predicted that the down-regulation of eight of these proteins may inhibit viral infection. Our results suggested that apart from inhibiting the NS2B/NS3 DENV2 protease, YK51 may also be causing the down-regulation of a number of proteins that may be responsible in, and/or essential to virus infection. However, functional characterization of these proteins will be necessary before we can conclusively determine their roles in DENV infection. |
format | Online Article Text |
id | pubmed-5796277 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57962772018-02-05 Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection Tan, Wei-Lian Lee, Yean Kee Ho, Yen Fong Yusof, Rohana Abdul Rahman, Noorsaadah Karsani, Saiful Anuar PeerJ Molecular Biology Dengue is endemic throughout tropical and subtropical regions of the world. Currently, there is no clinically approved therapeutic drug available for this acute viral infection. Although the first dengue vaccine Dengvaxia has been approved for use in certain countries, it is limited to those without a previous dengue infection while the safety and efficacy of the vaccine in those elderly and younger children still need to be identified. Therefore, it is becoming increasingly important to develop therapeutics/drugs to combat dengue virus (DENV) infection. YK51 is a synthetic analogue of 4-Hydroxypandurantin A (a compound found in the crude extract of the rhizomes of Boesenbergia rotunda) that has been extensively studied by our research group. It has been shown to possess outstanding antiviral activity due to its inhibitory activity against NS2B/NS3 DENV2 protease. However, it is not known how YK51 affects the proteome of DENV infected cells. Therefore, we performed a comparative proteomics analysis to identify changes in protein expression in DENV infected HepG2 cells treated with YK51. Classical two-dimensional gel electrophoresis followed by protein identification using tandem mass spectrometry was employed in this study. Thirty proteins were found to be down-regulated with YK51 treatment. In silico analysis predicted that the down-regulation of eight of these proteins may inhibit viral infection. Our results suggested that apart from inhibiting the NS2B/NS3 DENV2 protease, YK51 may also be causing the down-regulation of a number of proteins that may be responsible in, and/or essential to virus infection. However, functional characterization of these proteins will be necessary before we can conclusively determine their roles in DENV infection. PeerJ Inc. 2018-01-30 /pmc/articles/PMC5796277/ /pubmed/29404200 http://dx.doi.org/10.7717/peerj.3939 Text en ©2018 Tan et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Molecular Biology Tan, Wei-Lian Lee, Yean Kee Ho, Yen Fong Yusof, Rohana Abdul Rahman, Noorsaadah Karsani, Saiful Anuar Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection |
title | Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection |
title_full | Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection |
title_fullStr | Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection |
title_full_unstemmed | Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection |
title_short | Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection |
title_sort | comparative proteomics reveals that yk51, a 4-hydroxypandurantin-a analogue, downregulates the expression of proteins associated with dengue virus infection |
topic | Molecular Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796277/ https://www.ncbi.nlm.nih.gov/pubmed/29404200 http://dx.doi.org/10.7717/peerj.3939 |
work_keys_str_mv | AT tanweilian comparativeproteomicsrevealsthatyk51a4hydroxypandurantinaanaloguedownregulatestheexpressionofproteinsassociatedwithdenguevirusinfection AT leeyeankee comparativeproteomicsrevealsthatyk51a4hydroxypandurantinaanaloguedownregulatestheexpressionofproteinsassociatedwithdenguevirusinfection AT hoyenfong comparativeproteomicsrevealsthatyk51a4hydroxypandurantinaanaloguedownregulatestheexpressionofproteinsassociatedwithdenguevirusinfection AT yusofrohana comparativeproteomicsrevealsthatyk51a4hydroxypandurantinaanaloguedownregulatestheexpressionofproteinsassociatedwithdenguevirusinfection AT abdulrahmannoorsaadah comparativeproteomicsrevealsthatyk51a4hydroxypandurantinaanaloguedownregulatestheexpressionofproteinsassociatedwithdenguevirusinfection AT karsanisaifulanuar comparativeproteomicsrevealsthatyk51a4hydroxypandurantinaanaloguedownregulatestheexpressionofproteinsassociatedwithdenguevirusinfection |